SARS-CoV2 infection in whole lung primarily targets macrophages that display subset-specific responses
Thien-Phong Vu Manh,Carla Gouin,Julien De Wolf,Luc Jouneau,Florentina Pascale,Claudia Bevilacqua,Meriadeg Ar Gouilh,Bruno Da Costa,Christophe Chevalier,Matthieu Glorion,Laurent Hannouche,Céline Urien,Jérôme Estephan,Antoine Magnan,Morgan Le Guen,Quentin Marquant,Delphyne Descamps,Marc Dalod,Isabelle Schwartz-Cornil,Edouard Sage
DOI: https://doi.org/10.1007/s00018-024-05322-z
IF: 8
2024-08-18
Cellular and Molecular Life Sciences
Abstract:Deciphering the initial steps of SARS-CoV-2 infection, that influence COVID-19 outcomes, is challenging because animal models do not always reproduce human biological processes and in vitro systems do not recapitulate the histoarchitecture and cellular composition of respiratory tissues. To address this, we developed an innovative ex vivo model of whole human lung infection with SARS-CoV-2, leveraging a lung transplantation technique. Through single-cell RNA-seq, we identified that alveolar and monocyte-derived macrophages (AMs and MoMacs) were initial targets of the virus. Exposure of isolated lung AMs, MoMacs, classical monocytes and non-classical monocytes (ncMos) to SARS-CoV-2 variants revealed that while all subsets responded, MoMacs produced higher levels of inflammatory cytokines than AMs, and ncMos contributed the least. A Wuhan lineage appeared to be more potent than a D614G virus, in a dose-dependent manner. Amidst the ambiguity in the literature regarding the initial SARS-CoV-2 cell target, our study reveals that AMs and MoMacs are dominant primary entry points for the virus, and suggests that their responses may conduct subsequent injury, depending on their abundance, the viral strain and dose. Interfering on virus interaction with lung macrophages should be considered in prophylactic strategies.
cell biology,biochemistry & molecular biology